Qube Research & Technologies LTD Accuray Inc Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.06 - $3.18 $145,382 - $224,425	70,574 Added 71.59%	169,161 $502,000
Q4 2022 Feb 14, 2023	BUY	$1.88 - $2.4 $52,623 - $67,178	27,991 Added 39.65%	98,587 $206,000
Q3 2022 Nov 14, 2022	SELL	$1.92 - $2.97 $58,189 - $90,011	-30,307 Reduced 30.04%	70,596 $147,000
Q2 2022 Aug 15, 2022	BUY	$1.76 - $3.52 $53,664 - $107,328	30,491 Added 43.3%	100,903 $198,000
Q1 2022 May 09, 2022	BUY	$3.16 - $4.81 $58,447 - $88,965	18,496 Added 35.63%	70,412 $233,000
Q4 2021 Feb 01, 2022	BUY	$3.72 - $5.88 $193,127 - $305,266	51,916 New	51,916 $248,000

135

56M

26.2K

12.8K

Ticker ARAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 93,579,696
Market Cap $185M
Description
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation the...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.